Logo image of AIRS

AIRSCULPT TECHNOLOGIES INC (AIRS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AIRS - US0094961002 - Common Stock

2.03 USD
-0.14 (-6.45%)
Last: 12/26/2025, 8:27:44 PM
2.03 USD
0 (0%)
After Hours: 12/26/2025, 8:27:44 PM
Fundamental Rating

2

Taking everything into account, AIRS scores 2 out of 10 in our fundamental rating. AIRS was compared to 101 industry peers in the Health Care Providers & Services industry. AIRS may be in some trouble as it scores bad on both profitability and health. AIRS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AIRS had negative earnings in the past year.
AIRS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AIRS reported negative net income in multiple years.
In the past 5 years AIRS always reported a positive cash flow from operatings.
AIRS Yearly Net Income VS EBIT VS OCF VS FCFAIRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

AIRS has a worse Return On Assets (-9.67%) than 72.55% of its industry peers.
With a Return On Equity value of -21.90%, AIRS is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -9.67%
ROE -21.9%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
AIRS Yearly ROA, ROE, ROICAIRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With an excellent Gross Margin value of 63.97%, AIRS belongs to the best of the industry, outperforming 85.29% of the companies in the same industry.
AIRS's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AIRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
AIRS Yearly Profit, Operating, Gross MarginsAIRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60

0

2. Health

2.1 Basic Checks

AIRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
AIRS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AIRS has been increased compared to 5 years ago.
AIRS has a worse debt/assets ratio than last year.
AIRS Yearly Shares OutstandingAIRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AIRS Yearly Total Debt VS Total AssetsAIRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

AIRS has an Altman-Z score of 1.06. This is a bad value and indicates that AIRS is not financially healthy and even has some risk of bankruptcy.
AIRS has a Altman-Z score of 1.06. This is in the lower half of the industry: AIRS underperforms 73.53% of its industry peers.
AIRS has a debt to FCF ratio of 23.08. This is a negative value and a sign of low solvency as AIRS would need 23.08 years to pay back of all of its debts.
AIRS has a Debt to FCF ratio of 23.08. This is in the lower half of the industry: AIRS underperforms 60.78% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that AIRS is somewhat dependend on debt financing.
AIRS's Debt to Equity ratio of 0.63 is in line compared to the rest of the industry. AIRS outperforms 55.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 23.08
Altman-Z 1.06
ROIC/WACCN/A
WACC9.36%
AIRS Yearly LT Debt VS Equity VS FCFAIRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.51 indicates that AIRS may have some problems paying its short term obligations.
The Current ratio of AIRS (0.51) is worse than 87.25% of its industry peers.
A Quick Ratio of 0.51 indicates that AIRS may have some problems paying its short term obligations.
With a Quick ratio value of 0.51, AIRS is not doing good in the industry: 86.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
AIRS Yearly Current Assets VS Current LiabilitesAIRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

4

3. Growth

3.1 Past

AIRS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.14%.
Looking at the last year, AIRS shows a very negative growth in Revenue. The Revenue has decreased by -16.54% in the last year.
Measured over the past years, AIRS shows a very strong growth in Revenue. The Revenue has been growing by 34.35% on average per year.
EPS 1Y (TTM)7.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)-16.54%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.76%

3.2 Future

The Earnings Per Share is expected to grow by 18.40% on average over the next years. This is quite good.
AIRS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.37% yearly.
EPS Next Y52.4%
EPS Next 2Y24.82%
EPS Next 3Y18.4%
EPS Next 5YN/A
Revenue Next Year-17.19%
Revenue Next 2Y-7.85%
Revenue Next 3Y-3.3%
Revenue Next 5Y2.37%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AIRS Yearly Revenue VS EstimatesAIRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
AIRS Yearly EPS VS EstimatesAIRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2 0.3

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AIRS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIRS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIRS Price Earnings VS Forward Price EarningsAIRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AIRS.
AIRS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 51.4
EV/EBITDA 32.57
AIRS Per share dataAIRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

AIRS's earnings are expected to grow with 18.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.82%
EPS Next 3Y18.4%

0

5. Dividend

5.1 Amount

AIRS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AIRSCULPT TECHNOLOGIES INC

NASDAQ:AIRS (12/26/2025, 8:27:44 PM)

After market: 2.03 0 (0%)

2.03

-0.14 (-6.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-12 2026-03-12/amc
Inst Owners29.41%
Inst Owner Change1.48%
Ins Owners26.85%
Ins Owner Change0.3%
Market Cap126.75M
Revenue(TTM)157.55M
Net Income(TTM)-17.98M
Analysts76
Price Target6.63 (226.6%)
Short Float %31.99%
Short Ratio3.77
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-1.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)75.51%
Min EPS beat(2)-96.08%
Max EPS beat(2)247.1%
EPS beat(4)2
Avg EPS beat(4)28.68%
Min EPS beat(4)-103.64%
Max EPS beat(4)247.1%
EPS beat(8)3
Avg EPS beat(8)-16.15%
EPS beat(12)4
Avg EPS beat(12)-36.58%
EPS beat(16)5
Avg EPS beat(16)-86.46%
Revenue beat(2)0
Avg Revenue beat(2)-9.13%
Min Revenue beat(2)-13.2%
Max Revenue beat(2)-5.06%
Revenue beat(4)0
Avg Revenue beat(4)-7.84%
Min Revenue beat(4)-13.2%
Max Revenue beat(4)-1.64%
Revenue beat(8)0
Avg Revenue beat(8)-6.26%
Revenue beat(12)2
Avg Revenue beat(12)-3.89%
Revenue beat(16)5
Avg Revenue beat(16)-2.51%
PT rev (1m)0%
PT rev (3m)8.33%
EPS NQ rev (1m)-79.96%
EPS NQ rev (3m)-200%
EPS NY rev (1m)-250%
EPS NY rev (3m)-250%
Revenue NQ rev (1m)-6.19%
Revenue NQ rev (3m)-13.06%
Revenue NY rev (1m)-6.2%
Revenue NY rev (3m)-6.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.8
P/FCF 51.4
P/OCF 15.2
P/B 1.54
P/tB N/A
EV/EBITDA 32.57
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.04
FCFY1.95%
OCF(TTM)0.13
OCFY6.58%
SpS2.52
BVpS1.31
TBVpS-0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.67%
ROE -21.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.97%
FCFM 1.57%
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 23.08
Debt/EBITDA 9.48
Cap/Depr 45.53%
Cap/Sales 3.73%
Interest Coverage N/A
Cash Conversion 152.38%
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 1.06
F-Score3
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)124.96%
Cap/Depr(5y)109.63%
Cap/Sales(3y)6.83%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y52.4%
EPS Next 2Y24.82%
EPS Next 3Y18.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.54%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.76%
Revenue Next Year-17.19%
Revenue Next 2Y-7.85%
Revenue Next 3Y-3.3%
Revenue Next 5Y2.37%
EBIT growth 1Y-300.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.41%
EBIT Next 3Y12.29%
EBIT Next 5YN/A
FCF growth 1Y-84.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.59%
OCF growth 3Y-24.74%
OCF growth 5Y18.1%

AIRSCULPT TECHNOLOGIES INC / AIRS FAQ

What is the ChartMill fundamental rating of AIRSCULPT TECHNOLOGIES INC (AIRS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to AIRS.


What is the valuation status for AIRS stock?

ChartMill assigns a valuation rating of 1 / 10 to AIRSCULPT TECHNOLOGIES INC (AIRS). This can be considered as Overvalued.


What is the profitability of AIRS stock?

AIRSCULPT TECHNOLOGIES INC (AIRS) has a profitability rating of 2 / 10.


Can you provide the dividend sustainability for AIRS stock?

The dividend rating of AIRSCULPT TECHNOLOGIES INC (AIRS) is 0 / 10 and the dividend payout ratio is -1.32%.